Latvia Pharmaceuticals and Healthcare Report Q4 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Latvia Pharmaceuticals and Healthcare Report Q4 2013 Aug 7th 2013, 00:00, by rnrmahesh BMI View: After several years of budget cuts, which have had an impact on the healthcare sector, Latvia’s pharmaceutical market is re-emerging with steady growth forecast. Spending on pharmaceuticals will be driven by improved macroeconomic conditions. Meanwhile, the country’s manufacturing sector should benefit from its anticipated membership of the eurozone, which remains on track. Headline Expenditure Projections ? Pharmaceuticals: LVL222mn (US$409mn) in 2012 to LVL231mn (US$434mn) in 2013; +4.1% in local currency terms and +6.2% in US dollar terms. Forecast broadly unchanged from previous quarter. ? Healthcare: LVL946mn (US$1.74bn) in 2012 to LVL997mn (US$1.88bn) in 2013; +5.4% in local currency … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=110348. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/latvia-pharmaceuticals-and-healthcare-report-q4-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions